Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Degarelix evaluated in women undergoing in vitro fertilization

Nov. 5, 2012

Phase I results reported for ICT-107 in glioblastoma multiforme

Nov. 5, 2012

Karo Bio presents agent with potential for preventing multiple sclerosis progression

Nov. 2, 2012

Results presented from phase II trial of dovitinib in GIST

Nov. 2, 2012

Results presented for randomized phase II study of tivantinib

Nov. 2, 2012

Semaphorin-3A demonstrates osteoprotective qualities and therapeutic potential

Oct. 31, 2012

NCI presents phase II data for a cervical cancer vaccine

Oct. 31, 2012

Oral salmon calcitonin shows potential as antidiabetic therapy in vivo

Oct. 31, 2012

Preliminary phase II data presented for lubrinectedin in ovarian cancer

Oct. 31, 2012

Combination of BKM-120 and irinotecan evaluated in phase I trial

Oct. 31, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...